FDA Approves Zyn Nicotine Pouches Sales as Less Harmful for Philip Morris

AI Summary

The FDA authorized 20 Zyn nicotine pouch products owned by Philip Morris (PM) to be marketed with claims of being less harmful than traditional cigarettes. This regulatory approval represents a significant win for PM as it allows the company to promote its products as lowering risks associated with several smoking-related diseases. The FDA's decision does not indicate that Zyn is safe, reiterating that there's no safe tobacco product. This move aligns with a broader trend of declining cigarette sales and increasing investment in smoke-free alternatives by major tobacco companies.